Glycemic Control, Type II Diabetes, Parathyroidectomy

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

February 27, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

February 1, 2026

Conditions

Primary HyperparathyroidismType 2 Diabetes

Interventions

DIAGNOSTIC_TEST

Urine and Blood Test

Urine N-telopeptide and serum osteocalcin

Trial Locations (1)

Cleveland Clinic Main Campus, Cleveland

All Listed Sponsors

lead

The Cleveland Clinic

OTHER